The settlement’s existence after a 2017 accusation had been documented before the defense secretary nominee’s confirmation hearing this month, but the amount had not been known publicly.

Big business has an inside track in the second Trump presidency, and people with a stake in those businesses have reason to ...

Merck's blockbuster drug Keytruda and Eisai's cancer drug Lenvima, in combination with chemotherapy, failed to improve ...

The Host Julie Rovner KFF Health News @jrovner Read Julie's stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A ...

A recent health news roundup explores legal, financial, and strategic developments. Highlights include Robert F. Kennedy ...

Trump then went on to criticize the nation’s electric grid, calling it old while noting that he would allow the tech companies to rely on any fuel that they want to run the plants. And if the energy ...

Robert F. Kennedy Jr. is backing away from his anti-vaccine work as he vies for leadership of the Health and Human Services ...

Kennedy Jr.'s HHS nominee hearing with the U.S. Senate Finance Committee is set for Jan. 29. (FirstWord Pharma) Ahead of this ...

Department of Health and Human Services (HHS) secretary nominee Robert F. Kennedy Jr. plans to continue to receive referral fees from a law firm that is suing pharma powerhouse Merck & Co. | ...

The secretary of Health and Human Services nominee wrote in an ethics agreement that he would keep receiving contingency fees.

Robert F. Kennedy Jr. is distancing himself from his anti-vaccine work as he seeks to become the leader of the nation’s top health agency under President Donald Trump, according to reports.

Robert F. Kennedy, Jr, the nominee for Secretary of HHS, has made promises about the status of his stake in anti-vaccine nonprofits and notable pharma companies as his confirmation hearing approaches.